Skip to main content
OpenTrials

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

582 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumors trial results

Completed

A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers

NCT06345001

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • University of Southern California (USC) - Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
View Trial Details
Completed

Study of Avelumab-M3814 Combinations

NCT03724890

Conditions
Neoplasms, Oncology, Solid Tumors
Locations
  • H. Lee Moffitt Cancer Center and Research Institute, Inc Tampa, Florida, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • Mount Sinai - PRIME (10707) Lake Success, New York, United States
  • UC Health Clinical Trials Office (10702) Cincinnati, Ohio, United States
View Trial Details
Completed

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

NCT05225584

Conditions
Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
Locations
  • UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Hackensack University Medical Center, John Theurer Cancer Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Completed

A Study of E7130 in Participants With Solid Tumors

NCT03444701

Conditions
Carcinoma, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, +7 more
Locations
  • Eisai Trial Site 9 Nagoya, Aichi-ken, Japan
  • Eisai Trial Site 1 Kashiwa, Chiba, Japan
  • Eisai Trial Site 6 Kashiwa, Chiba, Japan
  • Eisai Trial Site 8 Sapporo, Hokkaido, Japan
View Trial Details
Completed

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors

NCT02667873

Conditions
Solid Tumors
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialist Sarasota, Florida, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Mary Crowely Cancer Research Centers- Medical City Dallas, Texas, United States
View Trial Details
Completed

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer

NCT02240238

Conditions
Solid Tumors
Locations
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Pacific Hematology Oncology Associates San Francisco, California, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
View all 22 locations
View Trial Details

Related conditions